eXoZymes, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -1,002.5% | – | – | – | – | – | – | – | – | – | |
| – | +18.6% | +6.5% | +8.5% | +1.1% | -1.9% | +4.3% | -238.5% | – | -473.3% | – | +3.8% | – | |
| – | +74.5% | +33.3% | +143.9% | -8.9% | +0.0% | +0.0% | +78.8% | -25.0% | +59.2% | -26.1% | +143.3% | – | |
| – | -69.4% | +1,296.6% | -246.2% | – | -678.5% | – | -44.6% | -140.8% | – | – | -40.4% | – | |
| – | -22.8% | +35.6% | -75.0% | -100.0% | – | -85.2% | +62.9% | -73.7% | +463.4% | -23.2% | -100.0% | – | |
| – | -22.8% | +29.8% | -73.9% | – | -781.9% | -85.2% | -0.6% | -56.9% | +463.5% | -23.2% | – | – | |
| – | – | – | – | – | – | – | – | -139.7% | -38.5% | +20.7% | +0.0% | – | |
| – | -5.8% | -118.9% | – | -77.6% | +2,526.9% | -100.3% | – | -139.7% | -38.5% | +20.7% | – | – | |
| – | -220.4% | – | -6.0% | +70.3% | +12,430.9% | -112.7% | – | – | – | – | – | – | |
| – | – | – | -2,045.0% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.